Founder and CEO Greg Piefer has received the University of Wisconsin-Madison Department of Physics’ 2019 Distinguished Alumni Award. The award is the highest honor presented to accomplished graduates of UW-Madison for their professional achievements, contributions to society and support of the university.
SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope.
SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors.
SHINE and Phoenix tested the first production-ready accelerator in SHINE’s Janesville facility over the course of 5.5 days to determine percentage uptime and total neutron output. The average system neutron yield was measured to be 10% percent beyond the required output, with greater than 99 percent uptime.
SHINE Breaks Ground on Medical Isotope Production Facility - First Commercial Sales of Life-Saving Medical Isotopes Expected in 2022. SHINE held a groundbreaking ceremony today to celebrate the start of construction of its US medical isotope production facility in Janesville, Wisconsin. The groundbreaking comes just one month after SHINE was transferred 91 acres of land across from the Southern Wisconsin Airport. Once complete, the facility will be home to eight of SHINE’s accelerator-based medical isotope production systems, capable of producing over one-third of global demand for the most widely-used medical isotope, molybdenum-99.
SHINE Medical Technologies and Deerfield Management Company, a healthcare investment firm, announced today the closing of a definitive agreement providing a $150 million financing commitment to support diagnostic and therapeutic medical isotope manufacturing.
Phoenix has delivered the first production accelerator to SHINE’s Building One, the first building on the SHINE medical isotope production campus in Janesville, WI.
SHINE was recently featured in ANS Nuclear News article about how we will soon be creating a stable supply of molybdenum-99.
Great article on moly-99 in the NYT, featuring SHINE.
Katrina Pitas, VP, Business Development September 1, 2017 - Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the [...]